* Avanos Medical Inc AVNS.N AVNS.K is expected to show a
fall
in quarterly revenue when it reports results on May 3.
* The Alpharetta Georgia-based company is expected to
report a
1.1% decrease in revenue to $195.2 million from $197.4 million a
year ago, according to the mean estimate from 3 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Avanos Medical Inc
is for
earnings of 27 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Avanos
Medical
Inc is $28, below its last closing price of $29.54.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 0.49 0.49 0.60 Beat 22.4
Sep. 30 2022 0.35 0.35 0.38 Beat 7.8
Jun. 30 2022 0.38 0.38 0.41 Beat 7.3
Mar. 31 2022 0.26 0.26 0.26 Met 0
Dec. 0.40 0.40 0.46 Beat 14.4
31 2021
Sep. 30 2021 0.29 0.30 0.25 Missed -17.1
Jun. 30 2021 0.23 0.23 0.21 Missed -10
Mar. 31 2021 0.18 0.19 0.23 Beat 24.3
This summary was machine generated May 1 at 15:57 GMT. All
figures in US dollars unless otherwise stated